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Crystallisation in printed droplets: understanding
crystallisation of D-mannitol polymorphs†
Asma Buanz, * Monica Gurung and Simon Gaisford
Crystallisation of mannitol in the confinement of inkjet printed droplets was studied; the effects of droplet
size and the presence of a foreign surface were investigated in comparison to the commonly used
manufacturing technique of spray drying. Only the metastable polymorphs (α and δ) were observed in
printed droplets with predominance of the α polymorph with increasing the droplet size, except for the
smallest droplets generated (∼100 pL) where the stable β polymorph was observed. The β polymorph was
also predominant in spray-dried samples, with metastable forms appearing upon the addition of a polymer
(Eudragit). We propose a dependence of the crystallisation of mannitol polymorphs on either the presence
or absence of a surface to favour either the stable or the metastable polymorphs. These findings expand
the experimental work that could be conducted to understand the crystallisation behaviour in droplets. By
proposing heterogeneous nucleation to favour the formation of the metastable polymorphs while homo-
geneous nucleation favouring the stable β polymorph, one might understand why the same manufacturing
method such as spray drying would produce one polymorph when processed alone but another when
present in a formulation. This is of great importance to the pharmaceutical industry to aid in understanding
the implications of crystallisation in manufacturing processes such as spray drying.
1. Introduction
Understanding crystallisation behavior of solid materials is
key for various industries ranging from food to electronics.1,2
This is especially evident for the pharmaceutical industry,
where the presence of various possible polymorphic and
pseudopolymorphic forms that could result from
crystallisation can affect not just the performance of the final
product but also the intellectual property for that product as
well as satisfying regulatory requirements.3–5
Crystallisation processes involve two main components:
nucleation and crystal growth.6–8 Depending on the presence
or absence of foreign particles or surfaces, nucleation can be
either homogeneous or heterogeneous. In the former, the
probability of nucleation to be homogeneous across the sys-
tem is high while in the latter there is a higher chance of the
nucleation to occur around foreign bodies. This is due to the
reduction of the energy barrier to nucleation when a foreign
surface is present, resulting in an enhanced nucleation
rate.7,8 Thus, the presence of a foreign surface can alter the
nucleation mechanism, which generally has a positive effect
by increasing the nucleation rate. Foreign particles could also
have a negative effect on nucleation if the nucleation on the
surface of these particles reduces the effective surface avail-
able for the incorporation of growth units, which would re-
sult in a net reduction in the nucleation rate.7
The effect of foreign particles on nucleation can be in-
creased by either maximising the interaction between the
crystallising phase and the surface of the particles, increasing
the relative size of the foreign particles or both. This would be
highly relevant in the case of crystallisation in confinement
where the effect of foreign surfaces is enhanced by the in-
creased area of surface interaction.9 Understanding such an
effect would help explain the behavior of materials in indus-
trial processes that involve both generation of small droplets
(confinement) and the presence or lack of solid surfaces (for-
eign surfaces) such as spray drying (where a solution of an ac-
tive pharmaceutical ingredient (API) and excipients is dried
while being suspended in hot air or gas). This might favour
the formation of one polymorphic form over others.10 Com-
paring crystallisation behavior of one component (say an API
or an excipient) when processed alone and then applying this
understanding to that of the material in a formulation can be
misleading, as foreign surfaces could also be the API or the
excipients used in the formulation.8 This is in addition to
other factors involved such as the mode and rate of supersatu-
ration generation and contact time with foreign surfaces.7
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An example is D-mannitol, a common pharmaceutical ex-
cipient that has three known polymorphic forms; the stable β
form (orthorhombic) and the metastable forms α (ortho-
rhombic) and δ (monoclinic).11 The thermodynamic relation-
ship between these polymorphs has been reported to be as
follows: δ (the lowest melting form) is enantiotropically re-
lated to β, α and β forms having similar melting points (166
°C and 166.5 °C, respectively) with the β form having a
slightly higher enthalpy of fusion (53.5 ± 0.4 versus 52.1 ± 0.9
kJ mol−1) and the two polymorphs are monotropically related,
as the density of the β form is 1.5% higher than that of the α
form.12 It has been reported that both thermodynamic and
kinetic properties affect the outcome of crystallisation of
D-mannitol from aqueous solutions with high dependency on
supersaturation.13 The resulting polymorphic form varies
when crystallised by various well-known industrial drying
methods. For instance, in aqueous solution the metastable
form δ crystallised (with a small amount of α) by freeze dry-
ing,12 while the stable β form was obtained by spray
drying.10,12,14–16 This might suggest that the drying tempera-
ture and/or fast evaporation result in the formation of the β
form as the fast evaporation rate achieved by spin coating
also resulted in the formation of the β form.17 However, the
β form was also obtained by slow evaporation of mannitol
aqueous solution while α by slow cooling of 70% ethanolic
solution.11 A concomitant crystallisation of β and δ forms
from slow evaporating micro-litre droplets was reported
where the amount of the metastable form increased by lower-
ing the relative humidity.17 When spray dried with proteins
the β form predominantly crystallised with some α form in
the presence of lysozyme, with the amount of the α form in-
creased with increasing the lysozyme content.10,15 Freeze dry-
ing mannitol with lysozyme solutions also resulted in the for-
mation of the β form with some δ form (not α).10 From this
it appears that crystallisation of mannitol polymorphs is also
affected by the presence of additives. But is the nature of
these additives important? Or other factors such as the mode
and rate of supersaturation generation might be the key to
understanding the crystallisation behaviour of mannitol poly-
morphs? From the examples mentioned above, there are two
main observations: (i) prevalence of concomitant
crystallisation of mannitol polymorphs and (ii) with methods
involving drying small solution droplets such as spray drying,
the δ form is not observed, while it appears with freeze
drying.
The first point highlights the similarities between the
polymorphic forms of mannitol evidenced by numerous re-
ports of the inter-conversion between them. The transforma-
tion is even reported in the absence of a solvent such as dur-
ing ball milling where β converts to α.18 The study indicated
that the conversion of the stable β form to the metastable α
form occurs with minimal microstructural modification. This
highlights the similarity between the crystal structure of the
two polymorphs: they crystallise in the same orthorhombic
space group P212121 (Table S1†), the conformation of the
main backbone is identical but there is a difference in the
OH group conformation with hydrogen bonding schemes, al-
though they have the same number of hydrogen bonds per
molecule and thus the conversion can be described as
displacive transformation where the crystal lattice is de-
formed rather than broken.18 The δ form has similar confor-
mation of the main backbone to the other two polymorphs
but deviates from the local C2 symmetry more than the α and
β forms in addition to being the most dense polymorph of
the three.11 Furthermore, solvent-mediated transformation is
also reported such as rapid solvent-mediated transformation
of δ polymorph to the stable β polymorph.11
The difference in the resulting polymorphs of mannitol
from two very common drying processes in the pharmaceuti-
cal industry that are mentioned in the second point empha-
sises the need to understand the factors that would affect the
crystallisation of a specific polymorph. This would aid in pro-
viding better control over the crystallisation of pharmaceuti-
cals. Nucleation, the first step of crystallisation, is governed
by the formation of the critical nuclei (crystal nuclei of suffi-
cient size) that is driven by supersaturation. This is then
followed by crystal growth until the supersaturation is con-
sumed. The difference between crystallisation in the bulk
and confinement is that in the bulk unlimited amount of the
material is assumed and thus crystallisation is usually con-
trolled by kinetic factors. This makes Ostwald's rule of stages
valid where the least stable form crystallises first and then
transforms to the more stable forms. Nonetheless, the rule is
empirical and not universally followed; although there are at-
tempts to employ it to explain the dependence of phase sta-
bility on the size of crystals.19,20 In confinement the amount
of material is limited and decreases as crystals grow. This
suggests that crystallisation in confinement can be either ki-
netically or thermodynamically controlled.9,21 This could ei-
ther result in the formation of the stable form or stabilisation
of the metastable forms. Chen et al. reported on controlling
the crystallisation of drugs such as glycine and mefenamic
acid into their stable forms by confinement in micro-
emulsion.22 Under such conditions crystallisation starts when
stable rather than critical nuclei formed.9,21,22 Other exam-
ples include stabilising metastable anthranilic acid form II in
nanoporous glass23 and the glycine β form by nano spray dry-
ing and bi-functional self-assembled monolayers.24
A key factor in controlling the outcome of crystallisation
in confinement is the size. However, this effect could vary
depending on the relative stabilities of the polymorphic
forms of any given material, with other factors such as sol-
vent mediated transformations adding to the complexity of
this effect. Inkjet printing (IJP) provides a flexible and robust
way for studying crystallisation in confinement by generating
droplets of varying sizes down to the picoliter range with pre-
cise deposition on virtually any surface. The well-developed
technique was introduced recently to pharmaceutics,25 with
limited reports on using IJP for investigating the
crystallisation behaviour of pharmaceuticals. The focus of print-
ing pharmaceuticals with IJP has been on maintaining drugs
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We have used the technique successfully for the fast prepara-
tion of co-crystals26 and the unstable β glycine polymorph,27
demonstrating its applicability to study the factors affecting
crystallisation in the confinement of the printed droplets.
An early work by Melendez et al.28 showed two polymorphs
of prednisolone crystallised from a solvent mixture solution
dispensed from a modified office printer onto
polyĲtetrafluoroethylene)-coated films. Crystallisation of poly-
mers such as polyĲε-caprolactone)40 or organic semiconduc-
tors41 by IJP was also reported.
Therefore, the aim of this work was to use inkjet printing
with changing the size of the printed droplets and the sub-
strate on which droplets are drying to access ranges of experi-
mental parameters that would be difficult to achieve by other
methods. For example, to use nanoporous silica or alumina
the material needs to be heated to just above its melting
point or annealed at a high temperature, which would not be
suitable for heat sensitive compounds.23,42 D-Mannitol was
chosen as a model material because of its importance as an
excipient commonly used in the pharmaceutical and food in-
dustries thus being heavily studied. This is in addition to the
complicated relationships between its polymorphs as




D-Mannitol (99%) was purchased from Alfa Aesar (UK) and
Eudragit RS PO was obtained from Evonik Industries (Evonik
Röhm GmbH, Germany) and used as received. Solvents used
were distilled water, HPLC grade water (Fisher Scientific),
and absolute ethanol (Fisher). Substrates used for printing
were glass slides (Thermo scientific, Germany) and alumin-
ium foil (Fisher). Slides were cleaned by sonication in 2% v/v
cleaning solution (Micro-90® concentrated cleaning solution,
Sigma Aldrich, USA) for 15–30 minutes, rinsed and sonicated
with distilled water for 15–30 minutes then dried in a fan
oven at 70 °C.
2.2 Inkjet printing
A Jetlab™ 4XL-A research printing platform (MicroFab tech-
nologies Ltd, USA) was used to print droplets onto different
substrates. The piezoelectric system allows dispensing of in-
dividual and multiple droplets. D-Mannitol solution (0.5 M)
in HPLC-grade water was filtered through a 0.45 μm
Nalgene™ PTFE filter (Thermo Scientific, USA) and dis-
pensed from a 40 μm nozzle (MJ-AT-01) dispensing device at
300 Hz using a driving voltage of 20 V and a pressure of −0.2
psi above the printing solution. Various numbers (1 to 2000)
of droplets were dispensed onto glass slides, aluminium foil
or Micromesh™ powder X-ray diffraction (PXRD) mounts. A
horizontally mounted camera allowed the observation of
printed droplets and calculation of their properties with the
dedicated droplet analysis software while a downward-
looking camera was used to inspect the printed material. Im-
ages of drying droplets collected with the downward-looking
camera were used to calculate the crystallisation induction
time and droplet diameter change using ImageJ software (Fiji
project43). Microliter droplets of the filtered solution of 0.5 M
D-mannitol in water were placed on glass or aluminium foil
using a 20 μL Gilson pipette and were allowed to evaporate at
room temperature and humidity until complete dryness.
2.3 Spray drying
Spray drying was performed using a Buchi B-290 mini spray
dryer (Buchi Labortechnik, CH-Flawil, Switzerland), used with
either an open-system for aqueous solutions or closed-system
(Inter Loop B-295 operated at −20 °C) for solutions
containing ethanol. Drying and atomising gases were com-
pressed air or nitrogen for open and closed-system, respec-
tively. The spray nozzle used has an inner diameter of 0.7
mm and orifice diameter of 1.5 mm. Solutions were either
0.5 M mannitol in water or mannitol : Eudragit RS PO (at 10,
30, 50, 70 and 90% w/w of polymer of the total dry weight)
using the ethanol and water solvent mixture (at 10, 30, 50, 70
and 90% ethanol, respectively). Process parameters used were
as follows: drying gas inlet temperature = 120 °C, atomising
gas flow = 439 L h−1 (30 mm), drying gas flow rate = 36 L
min−1 (aspiration 100%), liquid feed flow rate = 5 mL min−1
(15%), drying gas outlet temperature = 60 °C.
2.4 Raman microscopy
Raman spectra were collected using a Labram 200, Horiba
Scientific Ltd, equipped with a HeNe laser operated at 632.8
nm and an Olympus optical microscope. Spectra were col-
lected between 100 and up to 3200 cm−1 every 10 seconds,
with 4 accumulations using a long working distance objective
lens (50×). Data capture was performed using LabSpec5 soft-
ware. Spectra were collected from droplets of varying sizes
and presented from the same droplets in each graph.
2.5 Powder X-ray diffraction
Measurements were performed on a Rigaku MiniFlex 600 dif-
fractometer (Rigaku, Tokyo, Japan), which uses Cu Kα radia-
tion (1.5418 Å) at 40 kV and 15 mA. The patterns were col-
lected in the 2θ range from 3 to 35° at a speed of 2° min−1
and a step size of 0.01°. An Oxford Diffraction Xcalibur
NovaT X-ray diffractometer (Cu Kα radiation, λ = 1.5418 Å)
operated at room temperature was used to collect diffraction
data from samples crystallized on the PXRD Micromesh. The
sample was mounted using transmission geometry,
processed, and scaled using CrysAlisPRO software (Rigaku
Oxford Diffraction). The sample was mounted perpendicular
to the phi axis and rotated over 360° at 0.25° s−1.
3. Results and discussion
Controlled deposition of droplets of D-mannitol aqueous so-
lution was possible with inkjet printing, allowing the deposi-
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and aluminium surfaces. Mannitol formed spherulites upon
drying as shown in Fig. 1. Physical form analysis was
performed to identify the resulting polymorphic forms and to
investigate the factors affecting their crystallisation.
Due to the small size of the crystals formed and difficulty
in performing standard powder X-ray diffraction (PXRD), Ra-
man microscopy was used instead to identify the polymor-
phic forms produced as the technique is sensitive to the dif-
ferences in the lattice vibrations of different polymorphic
forms.44 D-Mannitol polymorphs can be distinguished from
their Raman spectra; the characteristic bands for D-mannitol
polymorphs are single peaks at 876, 1037 and 1136 cm−1 for
β, a double peak with maxima at 876 and 887 cm−1 and sin-
gle peaks at 1030, 1130, 1355 cm−1 for α, and similarly a dou-
ble peak at 876 and 887 cm−1 with a difference in the inten-
sity ratio, and single peaks at 1054 and 1250 cm−1 for δ.17,45
The Raman spectra collected from crystals formed in a
100 nL drop printed on a glass slide are depicted in Fig. 1b.
They indicate crystallisation of the δ form with evidence of
the presence of the α form too. The two metastable poly-
morphs δ and α also crystallised in all droplets of varying
sizes up to 200 nL, with the presence of the α form increased
as the droplet size increased (Fig. 1c and S1a†). The forma-
tion of the metastable forms of mannitol is consistent with
our previous observation of the formation of the metastable
β form of glycine by the confinement in printed drops.27
However, in the smallest printed drop of 100 pL, mainly the
stable β form of mannitol crystallised as shown from the Ra-
man spectra in Fig. 2.
To collect PXRD data on printed droplets we used an ap-
proach we developed before.27 It involves printing droplets
directly onto XRD micromeshes (400 μm in diameter) that
are conventionally used to collect small crystal form solu-
tions. The SEM images of mannitol crystals formed in a 10
nL drop printed onto the XRD mesh are shown in Fig. 3a and
the PXRD patterns are depicted in Fig. 3b.
A similar behaviour was observed on the aluminium sur-
face, where both α and δ polymorphs crystallised. Nonethe-
less, the appearance of the α form was observed in larger
droplets rather than on glass (Fig. S1b†). The two substrates
used, glass and aluminium, have different hydrophilicity
resulting in different contact angles as shown in Fig. 4a, with
average values of 37.4 ± 1.8° and 79.1 ± 0.7° on glass and alu-
minium, respectively (measured for water).
The behaviour of the droplet once in contact with the sur-
face is also different which could be measured by the change
in droplet diameter with time. This change can reflect on the
hysteresis of printed drops on solid substrates.46 Depicted in
Fig. 4b is the change of drop diameter up to the start of
crystallisation (i.e. during the crystallisation induction pe-
riod). The average change was 20.9 ± 9.3% on glass and only
5.2 ± 7.3% on aluminium. There was no clear correlation be-
tween the drop size and the degree of this change. This
change was not significantly different with the droplet size
on aluminium (p < 0.05). The value of the contact angle and
the level of wetting of that surface reflect the spreading of
droplets on substrates. Thus, the lower the value of the con-
tact angle the higher the wetting and the higher the degree
of the droplet diameter change during the droplet drying
process.
Crystallisation appears to start from the edge of the drops
(contact line) as shown in Fig. 5a, with clear formation of the
Fig. 1 (a) PLM images of mannitol crystals in a 100 nL droplet printed
on a glass slide, (b) and (c) Raman spectra from crystals formed in 100
and 200 nL droplets (the star indicates the band characteristic of the δ
form and the circle indicates the band characteristic of the α form).
Fig. 2 (a) Images of single droplets on glass (left) and aluminium
(right) and (b) Raman mapping results for one single 100 pL droplet on
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coffee-ring effect, where crystals are deposited around the cir-
cumference of the dried droplet. As the droplet dries, the rate
of evaporation at the edge is fastest and the droplet's contact
line is pinned by a capillary flow. This guarantees the replace-
ment of the evaporated liquid from the edges by the liquid
from the bulk of the drop. As a result, the dissolved material
will be carried by capillary flow to the edge. This means that
as the droplet dries the concentration of the solute increases
at the edge, generating a region with a higher degree of
supersaturation than in the bulk47 (further images are pro-
vided in Fig. S3 and Videos VS1–VS3†). The induction time
increased linearly with the increase in the droplet size on
both substrates (Fig. 5b), although the evaporation rate in-
creased with increasing droplet size (Fig. S4†). Thus the in-
duction time increased as a result of the increased flow of
the solvent to the edge of the droplet. What is more,
crystallisation was faster on glass, which correlates well with
the mode of droplet spreading on the two substrates as more
spreading (higher % of droplet diameter change) results in
faster evaporation and thus faster crystallisation (i.e. shorter
crystallisation induction time).
The largest droplet size studied by printing was 200 nL
(made out of 2000 droplets printed in microseconds on one
spot). To study crystallisation in droplets in the microliter
range, they were micro-pipetted onto the substrates. Character-
istic peaks for α and δ polymorphs are observed in crystals
formed in droplets up to 10 μL on glass slides, which is simi-
lar to printed droplets. Raman spectra were also collected dur-
ing the drying of a 0.2 μL droplet showing only the progres-
sion of the appearance of the α polymorph (Fig. S5 and S6†).
To collect PXRD data, microliter drops were also pipetted
onto a different type of a PXRD holder (glass holder), which
allowed the collection of PXRD data on crystals from microli-
ter droplets. The peaks for α as well as δ polymorphs are ob-
served in all droplets, with peaks for the β form appearing in
larger droplets (60 μL) (Fig. S7a and b†).
Concomitant crystallisation of mannitol is a common phe-
nomenon,48,49 with reports of cross-nucleation especially of
the α form.8 Therefore, competing thermodynamic and ki-
netic factors results in the concomitant crystallisation of
D-mannitol polymorphs. This would favour the nucleation,
growth or conversion of one polymorph over the other. The
observation of domination of the α form as the drop size
Fig. 3 (a) SEM images of crystals formed in printed droplets on an
XRD mesh (10 nL) and (b) XRD patterns for crystals formed in printed 5
and 10 nL droplets showing characteristic peaks for the α polymorph
(calculated reference PXRD patterns for mannitol polymorphs are
given in Fig. S2†).
Fig. 4 (a) Lateral images of a drop of water on glass and aluminium
substrates and (b) change of the diameter up to the start of
crystallisation of printed drops as a function of drop size.
Fig. 5 (a) Images of 100 nL droplets on glass and aluminium foil
substrates with the red arrow indicating the point of start of
crystallisation and red dotted-line circles indicating coffee-ring forma-
tion during droplet drying, and (b) crystallisation induction time as a
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increases could indicate that as the evaporation slowed down
a possible conversion of the δ form to the α form occurs. Ob-
serving a 10 μL droplet on glass shows clear conversion in
crystals following crystallisation while they were still in con-
tact with the remaining solvent (Fig. S8 and Video VS4†). An-
other explanation would be that the α form favours nucle-
ation on solid surfaces (the surface induced polymorph).
This means that the larger the surface the solution is in con-
tact with, the bigger the chance of nucleating the α form.
This would explain the formation of this form on both sub-
strate materials used here and why it forms in smaller drop-
lets on glass (more solution spreading) rather than alumin-
ium (less spreading).
It was interesting to notice the β form in both large μL
drops and very small (∼100 pL) printed drops. This could be
explained by two different factors at these droplet sizes ex-
tremes; observations of the β form crystallising in bulk solu-
tion have been reported, which is consistent with it being the
most stable form to which the other polymorphs convert to
eventually in the presence of excess solvent (water).50 On the
other hand, the confinement in the very small drop of 100 pL
might have caused the relative stability of mannitol poly-
morphs to change and thus the β form has become metasta-
ble and nucleated first, and due to the fast evaporation it did
not convert to the now stable forms (α and δ). This could be
possible as crystallisation in the confinement of nanopores
can result in a change in the stability ranking of poly-
morphs.9,51,52 Nonetheless, we do not believe that this is the
case here. Another explanation would be that the β form re-
quires homogeneous nucleation, which would be in the ab-
sence of surface or foreign particles. In such small droplets
the evaporation is very rapid such that the droplet behaves as
if there is no surface and thus results in the formation of the
β form. From the light microscopy images of single droplets
the absence of coffee-ring formation is clear (Fig. 2a), as the
convection flow that supplies the edge of the droplet with sol-
ute molecules is inhibited at such a small scale,53 which pre-
vents the formation of the coffee-ring. Convection promotes
heterogeneous nucleation and thus factors suppressing con-
vection appear to promote homogeneous nucleation7 and the
absence of this effect possibly encourages homogeneous nu-
cleation, which supports the formation of the β polymorph.
We have not been able to measure the supersaturation at the
point of nucleation but envisage that this would enhance the
understanding of the nature of nucleation of different
polymorphs.
Comparison with spray drying
An appropriate comparison would be with a drying method
that involves fast evaporation of droplets without the pres-
ence of a solid surface. Spray drying was chosen as in this
technique the solution is atomised into small droplets di-
rectly into a stream of hot air or gas.54 This provides a fast
evaporation of the solvent and thus could be comparable to
the evaporation rate in small printed droplets. As the drop-
lets are suspended in hot air or gas, they do not come in con-
tact with any solid surface.
Mannitol was spray dried with and without the presence
of a polymer (Eudragit®). Eudragit RS PO is a
polymethacrylate-based copolymer that is insoluble in water
but soluble in organic solvents,55 therefore, solutions for
spray drying that contained this polymer were prepared with
a mixture of water and ethanol. Powder samples were col-
lected and characterised with PXRD and Raman spectro-
scopy. PXRD results show that only the β form is observed
when mannitol was spray dried alone both from water and
water and ethanol mixtures (Fig. S9†) and with 10% w/
w polymer (Fig. 6). On the other hand, the α form was ob-
served in the sample containing 30% w/w polymer while the
δ form appeared in the samples containing 50 and 70% w/
w polymer. At 90% w/w polymer content the sample was pre-
dominantly amorphous (Fig. 6). The DSC results are consis-
tent with the PXRD results showing a shift of the endother-
mic transition in the samples with the higher concentration
of the polymer to a lower temperature indicating the melting
of the δ polymorph (155 °C)12 (Fig. S10†).
This is consistent with the reports in the literature men-
tioned earlier of the β form being observed by spray drying of
aqueous solutions while adding enzymes to the solution in-
creased the formation of the α form.15 The enzyme was ob-
served to accumulate on the surface of the particles and thus
Fig. 6 a) SEM images and b) PXRD patterns of spray dried mannitol
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the authors suggest that this slowed down drying by reducing
water transportation to the surface. It is not clear though
how that would favour the formation of the metastable α
form.15 Another explanation based on our findings from this
current study would be that the enzyme acted as a heteroge-
neous surface for nucleation and thus the α form was pre-
ferred, as in the case with printed droplets in our study,
while in the absence of the enzyme the β form was favoured.
The size of spray-dried particles was between 2.5 and 15
μm as shown in the SEM images presented in Fig. 6a and
S9.† This is smaller than that of the printed droplets in which
the β form was observed (60 μm) and could mean that spray
drying even larger droplets should still result in the forma-
tion of the β form. This has been reported where larger drop-
lets (up to 1.5 mm) were subjected to a similar condition as
in spray drying using the solvent levitation method. In this
method a single droplet is suspended in an ultrasonic field
and in the presence of a drying gas.15 The β form was ob-
served in these experiments with the presence of the α form.
When lysozyme was introduced the amount of the α form in-
creased until the higher concentration of the enzyme β form
was not observed. This is consistent with our hypothesis that
the presence of a foreign particle or surface favours the nu-
cleation of the α form, as well as it is being the fast growing
polymorph among mannitol polymorphs, while the β form is
preferred in the absence of a heterogeneous surface. The lat-
ter is consistent with the observation of either the α or δ
form from the melt but never β.56,57
This does not rule out the possibility of the crystallisation
of the β form and then converting to α or δ forms in such
large (microliter) droplets, as real time identification of the
polymorphic forms as the printed droplet where drying was
not possible, especially with Raman microscopy as the signal
was too weak in the presence of the solvent. This could be
ruled out in smaller droplets where evaporation is very fast
that chances of solvent-mediated transformation are very low.
The air–water interface appears to play an important role in
crystallisation from both printed and spray dried droplets.
The role of this interface in the crystallisation and denatur-
ation of proteins in spray-dried droplets has been investi-
gated58 but further work is required to improve understand-
ing of its role in the crystallisation of small molecules.
4. Conclusions
Inkjet printing allows very fine control over droplet size,
which enabled the study of the crystallisation behaviour of D-
mannitol's closely related polymorphs. In summary (i) the
confinement in the smallest printed droplets of ca. 100 pL
favoured the formation of the stable β form, (ii) larger drop-
lets in nL size range promoted the crystallisation of the meta-
stable forms with fast evaporation possibly prevented solvent-
mediated transformation to the stable form and (iii) slow
evaporation in microliter droplets resulted in the
crystallisation of β and the least stable δ form. Evidence sug-
gests that the α polymorphs favour nucleation on the solid
surface.
The findings from spray drying indicate that confinement
within sprayed droplets and the very fast evaporation rate
favoured the formation of the β form despite the droplet size
being larger than that of the printed ones where the β form
was obtained (μL versus pL). Spray drying with a polymer ap-
pears to favour the formation of the metastable form α,
which supports the hypothesis of it being a surface-induced
polymorph. Further work is required to provide clearer evi-
dence on the nature of the nucleation being either homoge-
neous or heterogeneous. This also highlights the applicability
of inkjet printing in investigating crystallisation in confine-
ment which can help understand the crystallisation behav-
iour in commonly used manufacturing techniques such as
spray drying. It also aids in studying general crystallisation in
thin films to much smaller droplets as usually larger droplets
are studied. In addition, studying crystallisation in confine-
ment with printing is different from other approaches where
heating is required, such as with confinement in nanoporous
materials, which is not suitable for heat-sensitive materials.
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